Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

Completed · Phase 3 · Has a placebo group

Conditions studied: COVID-19, SARS-CoV-2

In brief

The aim of the study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.

Key facts

Study ID

NCT04516746

Run by

AstraZeneca

People needed

32450

Starts

2020-08-28

Expected to finish

2023-02-10

Last updated by the study team

2024-02-05

Who can join

Age: 18 and older, up to 130. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Increased risk of SARS-CoV-2 infection
• Medically stable

You may not qualify if…

• confirmed or suspected immunosuppressive or immunodeficient state
• significant disease, disorder, or finding
• Prior or concomitant vaccine therapy for COVID-19

Where it is running

• Research Site — Scottsdale, Arizona, United States
• Research Site — Little Rock, Arkansas, United States
• Research Site — Berkeley, California, United States
• Research Site — El Centro, California, United States
• Research Site — Los Angeles, California, United States
• Research Site — Los Angeles, California, United States
• Research Site — San Diego, California, United States
• Research Site — San Diego, California, United States
• Research Site — San Francisco, California, United States
• Research Site — San Francisco, California, United States
• Research Site — Torrance, California, United States
• Research Site — Denver, Colorado, United States
• Research Site — Danbury, Connecticut, United States
• Research Site — Coral Gables, Florida, United States
• Research Site — Lake Worth, Florida, United States
• Research Site — Miami Lakes, Florida, United States
• Research Site — Orlando, Florida, United States
• Research Site — Honolulu, Hawaii, United States
• Research Site — Meridian, Idaho, United States
• Research Site — Chicago, Illinois, United States
• Research Site — Indianapolis, Indiana, United States
• Research Site — Ankeny, Iowa, United States
• Research Site — Fairway, Kansas, United States
• Research Site — Kansas City, Kansas, United States
• Research Site — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.